Position in PFE
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$60,729
-$10,088 QoQ
Shares Held
2,522
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,601
of 2,821 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Security National Bank holds $9,534,118 across 10 Drug Manufacturers - General names. PFE ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,085 | $3,831,137 | |
| 2 | LLY |
ELI LILLY & Co
|
2,326 | $2,789,874 | |
| 3 | AZN |
Astrazeneca PLC
|
8,964 | $1,699,753 | |
| 4 | AMGN |
Amgen Inc
|
1,713 | $620,311 | |
| 5 | ABBV |
AbbVie Inc.
|
1,182 | $297,437 | |
| 6 | GSK |
GSK plc
|
2,359 | $123,658 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,294 | $74,560 | |
| 8 | PFE |
Pfizer Inc
This page
|
2,522 | $60,729 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,729 | 2,522 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $70,817 | 2,522 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $62,797 | 2,522 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $64,260 | 2,522 | Shares | Defined | 2025-10-20 | |
| 2025-06-30 | $61,133 | 2,522 | Shares | Defined | 2025-07-10 | |
| 2025-03-31 | $59,346 | 2,342 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $59,745 | 2,252 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $65,172 | 2,252 | Shares | Defined | 2024-10-07 | |
| 2024-06-30 | $63,010 | 2,252 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $62,493 | 2,252 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $64,835 | 2,252 | Shares | Defined | 2024-02-13 | |
| 2023-06-30 | $218,539 | 5,958 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $241,209 | 5,912 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $302,930 | 5,912 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $257,221 | 5,878 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $435,378 | 8,304 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $764,953 | 14,776 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $682,204 | 11,553 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $541,280 | 12,585 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $401,468 | 10,252 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $371,429 | 10,252 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $249,277 | 6,772 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $248,532 | 6,772 | Shares | Sole | 2020-10-19 | |
| No filing history on record for this holder in this stock. | ||||||